Wedbush Analysts Raise Price Target on Oncothyreon Inc . (ONTY) to $15.00
Thursday, June 23, 2021 9:30 AM

Equities research analysts at Wedbush boosted their price target on shares of Oncothyreon Inc . (NASDAQ: ONTY) to $15.00 in a research note to investors on Thursday.

Separately, analysts at Cowen initiated coverage on shares of Oncothyreon Inc . in a research note to investors on Tuesday, May 31st. They set an "outperform" rating on the stock. Also, analysts at Zacks Investment Research reiterated a "neutral" rating on shares of Oncothyreon Inc . in a research note to investors on Thursday, May 12nd.

Shares of Oncothyreon Inc . opened at 8.15 on Friday. Oncothyreon Inc . has a 52 week low of $2.99 and a 52 week high of $9.44. The stock's 50-day moving average is $6. and its 200-day moving average is $4.19. The company has a market cap of $339.0 million.

Oncothyreon Inc. (Oncothyreon) is a clinical-stage biopharmaceutical company. The Company focuses primarily on the development of therapeutic products for the treatment of cancer. Oncothyreon’s cancer vaccines are designed to stimulate the immune system to attack cancer cells, while its small molecule compounds are designed to inhibit the activity of specific cancer-related proteins. The Company’s lead product candidate under clinical development is a vaccine it calls Stimuvax. Stimuvax incorporates a 25 amino acid sequence of the cancer antigen MUC1, in a liposomal formulation. Stimuvax is designed to induce an immune response to destroy cancer cells that express MUC1, a protein antigen widely expressed on many common cancers, such as lung cancer, breast cancer and colorectal cancer. Oncothyreon has granted an exclusive, worldwide license to Merck KGaA of Darmstadt, Germany (Merck KGaA), for the development, manufacture and commercialization of Stimuvax.

Stay on top of analysts' coverage with American Banking & Market News' daily email newsletter that provides a concise list of analysts' upgrades, analysts' downgrades and analysts' price target changes for each day.Click here to register.


 

Sponsors

Advertisement


Advertisement